Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

March 12, 2025

Aprea and MD Anderson sign agreement for APR-1051

Aprea Therapeutics has signed a material transfer agreement (MTA) with MD Anderson Cancer Center to explore APR-1051 for head and neck squamous cell carcinoma (HNSCC).

Aprea and MD Anderson sign agreement for APR-1051